MACLEAN ROBERT G 4
4 · BOSTON SCIENTIFIC CORP · Filed May 28, 2004
Insider Transaction Report
Form 4
MACLEAN ROBERT G
SVP, HR
Transactions
- Exercise/Conversion
Common Stock
2004-05-26+65,000→ 101,502 total - Sale
Common Stock
2004-05-26$42.90/sh−300$12,870→ 51,502 total - Sale
Common Stock
2004-05-26$42.72/sh−15,000$640,800→ 36,502 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-05-26−65,000→ 45,000 totalExercise: $8.50Exp: 2010-07-25→ Common Stock (65,000 underlying) - Sale
Common Stock
2004-05-26$42.18/sh−100$4,218→ 91,402 total - Sale
Common Stock
2004-05-26$42.80/sh−10,000$428,000→ 61,502 total - Sale
Common Stock
2004-05-26$42.90/sh−4,100$175,890→ 51,802 total - Sale
Common Stock
2004-05-26$42.95/sh−700$30,065→ 100,802 total - Sale
Common Stock
2004-05-26$42.92/sh−9,300$399,156→ 91,502 total - Sale
Common Stock
2004-05-26$42.10/sh−19,900$837,790→ 71,502 total - Sale
Common Stock
2004-05-26$42.90/sh−5,500$235,950→ 56,002 total
Holdings
- 8,033(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Savings Plan.
- [F2]Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on July 25, 2001, 50% on July 25, 2002, 75% on July 25, 2003 and 100% on July 25, 2004, the anniversary date of the grant.